Clinical trial

Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations

NCT07127094

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2025-03-09

PhasePHASE1

Study timeline

Study start (actual)2025-03-09Date precision: day

Registry last updated2025-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Bioequivalence Study in Healthy Subjectsunresolved

Interventions

Test Product (Glimcoza)DRUG

Reference (R) Twymeeg®DRUG

Sponsors & collaborators

Aya Mohammed Abdel Magid Abdel Hamidlead sponsor

Advanced Research Center (ARC)collaborator

Atco Pharma for Pharmaceutical Industriescollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07127094 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.